论文部分内容阅读
近年来国内对急性非淋巴细胞白血病（ＮＡＬＬ）采取的治疗方案多种多样，疗效不一，１９９５年—１９９７年我院采用米托蒽醌（ＭＴＺ）联合阿糖胞苷（Ａｒａ－Ｃ）方案治疗ＡＮＬＬ２０例，现报告如下。１ 材料与方法１．１ 病例 １９９５年７月—１９９７年７月住院的Ａ
In recent years, the treatment options for acute non-lymphocytic leukemia (NALL) in China have been varied and have different therapeutic effects. In 1995-1997, our institute adopted Mitoxantrone (MTZ) combined with cytarabine (Ara-C) regimen. Treatment of 20 cases of ANLL is as follows. 1 Materials and Methods 1.1 Cases A hospitalized from July 1995 to July 1997